Alnylam Pharmaceuticals, Inc.

OPPENHEIMER & CO INC ALNY

Report date

12/31/2025

Quarter

2025 Q4

Filed

2/2/2026

Shares

966

Value ($000)

384

Weight

0.0%

2020 Q2 - 2025 Q4 (23 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2025 Q4	2/2/2026	384	0.0%	966	12/31/2025
2025 Q3	11/6/2025	782	0.0%	1,716	9/30/2025
2025 Q2	7/31/2025	560	0.0%	1,716	6/30/2025
2025 Q1	4/23/2025	463	0.0%	1,716	3/31/2025
2024 Q4	2/5/2025	404	0.0%	1,716	12/31/2024
2024 Q3	11/5/2024	524	0.0%	1,906	9/30/2024
2024 Q2	8/8/2024	417	0.0%	1,716	6/30/2024
2024 Q1	5/7/2024	256	0.0%	1,716	3/31/2024
2023 Q4	2/13/2024	838	0.0%	4,379	12/31/2023
2023 Q3	11/8/2023	800	0.0%	4,519	9/30/2023
2023 Q2	8/3/2023	841	0.0%	4,426	6/30/2023
2023 Q1	5/10/2023	857	0.0%	4,277	3/31/2023
2022 Q4	2/8/2023	1,028	0.0%	4,324	12/31/2022
2022 Q3	11/14/2022	859	0.0%	4,293	9/30/2022
2022 Q2	8/8/2022	738	0.0%	5,056	6/30/2022
2022 Q1	5/12/2022	819	0.0%	5,012	3/31/2022
2021 Q4	2/2/2022	482	0.0%	2,843	12/31/2021
2021 Q3	11/12/2021	441	0.0%	2,339	9/30/2021
2021 Q2	8/3/2021	397	0.0%	2,339	6/30/2021
2021 Q1	5/10/2021	331	0.0%	2,339	3/31/2021
2020 Q4	2/11/2021	304	0.0%	2,339	12/31/2020
2020 Q3	11/13/2020	335	0.0%	2,300	9/30/2020
2020 Q2	8/11/2020	341	0.0%	2,300	6/30/2020